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BACKGROUND: Cryptococcus neoformans is responsible of cryptococcosis, a life-threatening infection 
that affects healthy and immunocompromised individuals. It is the first cause of adult acute meningitis in 
some sub-Saharan African countries with a mortality rate of about 100% in cases of inappropriate 
therapy. This study aimed at examining the occurrence and the antifungal patterns of Cryptococcus 
isolates from pigeon droppings and bat guanos in the west region of Cameroon. 
METHODS: A total of 350 samples were randomly collected from three selected localities of west region 
of Cameroon. The identification was performed based on capsule production assessed by Indian ink 
preparation. Additional tests performed were urea broth, glycine and tryptophan assimilation tests. The 
antifungal susceptibility test was performed by the broth microdilution method. 
RESULTS: Mycological analysis led to the identification of 98 isolates, of which 57 isolates of C. 
neoformans var. gattii and 41 isolates of C. neoformans var. neoformans. All the isolates showed 
resistance to antifungals tested except  nystatin which showed MIC mean values ranging between 0.5 
µg/mL and 0.65 µg/mL.  
CONCLUSION: The prevalence of C. neoformans in pigeons and bats excreta in the west region of 
Cameroon is 28.57 %. C. neoformans var. gattii and C. neoformans var. neoformans are the main 
serotypes. Isolates found to be resistant to fluconazole and ketoconazole. Our results emphasize the need 
for further study on the molecular epidemiology in comparison with clinical isolates. 
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INTRODUCTION 
 
Cryptococcus neoformans is an encapsulated, 
ubiquitous environmental yeast that causes 
cryptococcosis, a potentially serious disease that 
affects healthy and immunocompromised 
individuals, especially patients with AIDS (1). It is 
actually the first cause of adult acute meningitis in 
some sub-Saharan African countries with a 
mortality rate of about 100% in cases of 
inappropriate therapy, and about 20% to 30% in 
cases of antifungal treatment (1,2). The 
aetiological agents of cryptococcosis comprise 
four serotypes grouped into two major species, 
namely, Cryptococcus gattii (serotypes B and C) 
and Cryptococcus neoformans, (serotype A and D) 
(3). These two species differ in their biochemical 
characteristics especially their amino acids 
assimilation ability and clinical characteristics 
(4,5). C. neoformans var. grubii is mostly 
incriminated in infections with 
immunocompromised hosts while C. 
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immunocompetent hosts (6,7,8). They also differ 
in their ecological niches and geographical 
distribution. Globally, the distribution of 
Cryptococcus species in nature is very large and is 
especially associated to decaying wood of certain 
species of trees, fruits and bird droppings, 
particularly pigeon droppings (9).  C. 
neoformans is commonly isolated from bird 
excreta while C. gattii has been isolated mainly 
from samples of eucalyptus and other trees around 
the world (10). As infection by C. neoformans 
occurs through inhalation of propagules from the 
environment, bird excreta as a source of infectious 
propagules could play a central role in the 
transmission of C. neoformans from the 
environment to humans. Therefore, bird excreta 
appear as a dangerous reservoir and potential 
source of inhaled C. neoformans. In the west 
region of Cameroon, pigeons are domesticated and 
therefore have a very close proximity to humans. 
In addition, there is an increasing presence of bats 
in urban areas, colonizing many tree species. 
Considering the incidence of human 
cryptococcosis in Cameroon and the fact that birds 
are becoming more close to humans in some 
regions, this study was undertaken to determine 
the prevalence of C. neoformans in pigeon 
droppings and bat guanos in three localities of the 
west region of Cameroon. Furthermore, the 
antifungal susceptibility of the isolates was 
evaluated against four commonly used antifungals. 
 
MATERIALS AND METHODS 
 
Study area and sample collection: The West 
Region is 13,892 km² of territory located in the 
central-western portion of the Republic of 
Cameroon. Its population is estimated to be 
1,834,800. Based on the high presence of bats and 
pigeons, three localities including Bafoussam, 
Dschang and Santchou were selected for the study.  
Isolation and identification of Cryptococcus 
species: Samples were randomly collected. Dry 
samples were collected with spatulas and placed in 
identified clean plastic bags. Wet samples were 
collected with a sterile cotton-tipped swab 
moistened in sterile saline solution (0.85 % NaCl) 
supplemented with chloramphenicol (10 µg/ml) 
and placed in a test tube with 3 ml of the same 
solution. The collected samples were transported 
in sterilized plastic bags. The samples were 
processed following the method described by 
Soogarun (11), but with slight modifications on 
the isolation procedure. One gram of each sample 
was dissolved in 9 mL of sterile physiological 
saline (0.9% aqueous NaCl) containing 0.4 mg/mL 
of chloramphenicol, vortexed vigorously for 1-3 
min and filtered through sterile gauze. After 10 
minutes, 50µL of supernatant was streaked onto 
Sabouraud’s dextrose agar plate containing 0.05 
mg/mL of chloramphenicol. Plates were then 
incubated at 37 °c for 3-21 days. Creamed round 
brown yeast-like colonies of suspected C. 
neoformans detected were subcultured on new 
Sabouraud dextrose agar tubes to obtain single 
colonies.  
Colony morphology and microscopic 
observation of the presence of capsule in India ink 
preparation were performed. Urease enzyme 
production was assessed on prepared indole-urea 
agar culture medium following the manufacturer’s 
protocol. For the biochemical tests, the 
auxanogram technique was used to differentiate, 
identify and confirm the specie variety. In fact, on 
glycine and tryptophan assimilation testing 
composed media based on the fact that only C. 
neoformans var. gattii isolates are able to use 
glycine and tryptophan as sole sources of nitrogen 
(4,5). For the test, 175µL of each composed media 
(media composition: glucose 20g/L, glycine 20g/L 
or tryptophan 4g/L and Chloramphenicol 0.05g/L) 
was introduced in 96 well microtiter plates and 
25µL of each solution prepared in concentrations 
corresponding to 0.5 on the Mac-Farland scale, 
was added. The plates were then incubated at 37 
°c for 48 to 72 hours, and the growth was 
recorded. C. neoformans KN99α (serotype A) was 
used as reference strain for control. 
Antifungal susceptibility testing: In addition to 
the reference clinical strains C. neoformans 
KN99α, ten isolates of each variety were 
randomly selected and tested for their antifungal 
susceptibility to four commonly used antifungals: 
namely, nystatin, amphotericin B, fluconazole and 
ketoconazole. The minimum inhibitory 
concentration was determined as recommended by 
the NCCLS (12). MIC values were interpreted as 
described by Lozano-Chiu et al. and Nguyen and 
Yu respectively (13,14) (Table 1). 
 
 




Table 1: Minimum inhibitory concentration (MIC) 
values interpretation  
 




Fluconazole ≤ 8 16- 32 ≥ 64 
AmphotericinB ≤ 1 2- 4 > 4 
Ketoconazole ≤ 0,125 0.25- 0.5 ≥ 1 




A total of 350 samples were collected over a 
period of eight months, from April to November 
2015. They were made up of 200 samples of 
pigeon droppings and 150 samples of bat guanos 
(Figure 1).  From the 350 samples collected, 103 
yeast-like Cryptococcus were isolated among 
which 101 showed capsules in the India ink 
preparation. The 101 India ink positive isolates 
subjected to urease enzyme test revealed 100 
positive and 01 negative. Therefore, 100 isolates 
were confirmed as Cryptococcus neoformans 
isolates (Table 2). Glycine and tryptophan 
assimilation results showed that, among the 100 
isolates positive to urease, 57 were of the 
Cryptococcus gattii variety, while 41 were of the 
Cryptococcus neoformans var neoformans 
(Cryptococcus neoformans) variety and 02 of the 
isolates remained undetermined (Table 3).  The 
antifungal results are presented in (Table 4).  
Compared to the reference clinical strain (MICs 
ranged from 4 µg/mL to 32 µg/mL), the antifungal 
susceptibility results showed high resistance of 
isolates to azole antifungals. The MICs values 
ranged from 16 µg/mL to > 256 µg/mL and from 8 
µg/mL to 64 µg/mL for fluconazole and 
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Figure 1: Distribution of samples according to the collection areas 
 
Table 2: Results of culture and microscopic observation in India ink 
 




% India ink 
(n=103) 
% Urease test  
(n=101) 
% Total % 
 
Positive 
PD 56 16 56 54.37 55 54.45 55 55 
BG 47 13.42 45 43.68 45 44.55 45 45 
Total 103 29.42 101 98,05 100 99 100 100 
 
Negative 
PD 144 41.14 0 0 1 1   
BG 103 29.44 2 1.95 0 0   
Total 247 70.58 2 1.95 1 1   
PD= Pigeon dropping; BG= Bat guanos  
 









Amino acid  










Gly 24 18 42 31 27 58 
Trp 23 19 42 32 26 58 
Trp+Gly 23 18 41 31 26 57 
Interpretation       
Cn var  neoformans    31 26 57 
Cn var gattii 23 18 41    
Undetermined 1 1 2    
Cn= Cryptococcus neoformans; PD= Pigeon dropping; BG=Bat guano; Gly=glycine; Trp=tryptophane 
 
Table 4: Antifungal susceptibility of isolates and a reference clinical strain determined by the minimum 





















Fluconazole Range  64 - >256 16 - >256 2 
 Mean - - 
Ketoconazole Range  16 - 64 8 - 64 1 
Mean 36.8 27.2 
Amphotericin B Range  4 - 8 64 - 128 2 
Mean 4.6 89.6 
Nystatin Range  0.125-0.5 0.5 - 1 0.5 
 Mean 0.35 0.65 




The incidence of opportunistic fungal infections 
has increased in recent years and is considered as 
an important public health problem. Several 
studies have shown that C. neoformans remains 
viable in the dried excrement of birds (15). 
Therefore bird excreta appear as a dangerous 
reservoir and potential source of C. neoformans 
infection. In this regard, 350 samples of pigeon 
droppings and bat guanos were collected in the 
west region of Cameroon and the isolates obtained 
were examined for their antifungal susceptibility. 
In this study, we observed an occurrence of 
C. neoformans in 100 out of the 350 samples 
analysed, indicating an incidence of 28.57 % of 
this yeast in the studied region. This result 
confirms the presence of this yeast in the 
environment, in the west region of Cameroon. 
Similar studies carried out in Nigeria and Jordan 
showed prevalences of 22.0% (39/177) and 33.3% 
(336/1009) respectively (16,17). However, in the 
above studies, the authors used only pigeon 
dropping and materials under canopies of 
eucalyptus trees for isolation, not bat guanos. In 
our study, the number of isolates obtained from 
pigeon droppings (55%) was higher than those 
recovered from bat guanos (45%), confirming 
pigeon droppings as an important reservoir of C. 
neoformans. Previous studies have described 
pigeon droppings as the main source of C. 
neoformans isolation (18). Nevertheless, with 45% 
of C. neoformans recovered from bat guanos, bats 
may also play an important role in the 
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epidemiology of cryptococcosis through their 
migratory characters. The presence of the two 
main varieties of C. neoformans, namely C. 
neoformans var. neoformans and C. neoformans 
var. gattii in the west region of Cameroon confirm 
the geographical distribution of C. neoformans as 
described in several previous studies (15, 5, 4, 19). 
In fact, most of these previous studies showed that 
C. neoformans var. neoformans has a worldwide 
distribution while C. neoformans var. gattii is 
associated with decaying wood in tropical and 
sub-tropical regions of the world. Nevertheless, 
Overy et al (20) identified the presence of 
Cryptococcus gattii in Canada showing that this 
pathogen colonizes other parts of the world.  
All the isolates tested showed resistance to 
fluconazole, ketoconazole and amphotericin B 
antifungals. Such a pattern of susceptibility from 
environmental C. neoformans isolates was not 
found in the literature. Most studies reported that 
environmental isolates of C. neoformans were 
susceptible to these antifungals (21,22). Gutch et 
al (23), using the microdilution method, verified 
the susceptibility profile of clinical and 
environmental isolates of Cryptococcus 
neoformans and Cryptococcus gattii in Jabalpur, a 
city of Madhya Pradesh in Central India. Although 
low sensitivity of environmental isolates to 
fluconazole has been demonstrated by Rossi et al 
(24), these results may draw the attention of 
clinician researchers on a prospective emergence 
of resistant clinical isolates since contamination 
can easily occur by inhalation of propagules from 
the environment. Contrary to amphotericin B, our 
isolates appeared to be susceptible to nystatin 
which is also an antifungal belonging to the 
polyene class.  
This study revealed that the prevalence of C. 
neoformans in the excreta of pigeons and bats in 
the west region of Cameroon is 28.57%, C. 
neoformans var. gattii and C. neoformans var. 
neoformans being the two main representative 
serotypes. Isolates were found to be resistant to 
fluconazole and ketoconazole. Considering the 
incidence of human cryptococcosis in Cameroon, 
especially in HIV patients, and the fact that 
pigeons and bats are widely spread birds in these 
localities, our results emphasize the need for 
further studies on the molecular epidemiology in 
comparison with clinical isolates. 
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